• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

污水处理厂及受纳河流中抗病毒药物、抗生素和解充血药在疫情期间及不同疫情间的变化情况。

Intra- and inter-pandemic variations of antiviral, antibiotics and decongestants in wastewater treatment plants and receiving rivers.

作者信息

Singer Andrew C, Järhult Josef D, Grabic Roman, Khan Ghazanfar A, Lindberg Richard H, Fedorova Ganna, Fick Jerker, Bowes Michael J, Olsen Björn, Söderström Hanna

机构信息

Natural Environment Research Council, Centre for Ecology and Hydrology, Wallingford, United Kingdom.

Section of Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

出版信息

PLoS One. 2014 Sep 25;9(9):e108621. doi: 10.1371/journal.pone.0108621. eCollection 2014.

DOI:10.1371/journal.pone.0108621
PMID:25254643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4177917/
Abstract

The concentration of eleven antibiotics (trimethoprim, oxytetracycline, ciprofloxacin, azithromycin, cefotaxime, doxycycline, sulfamethoxazole, erythromycin, clarithromycin, ofloxacin, norfloxacin), three decongestants (naphazoline, oxymetazoline, xylometazoline) and the antiviral drug oseltamivir's active metabolite, oseltamivir carboxylate (OC), were measured weekly at 21 locations within the River Thames catchment in England during the month of November 2009, the autumnal peak of the influenza A[H1N1]pdm09 pandemic. The aim was to quantify the pharmaceutical response to the pandemic and compare this to drug use during the late pandemic (March 2010) and the inter-pandemic periods (May 2011). A large and small wastewater treatment plant (WWTP) were sampled in November 2009 to understand the differential fate of the analytes in the two WWTPs prior to their entry in the receiving river and to estimate drug users using a wastewater epidemiology approach. Mean hourly OC concentrations in the small and large WWTP's influent were 208 and 350 ng/L (max, 2070 and 550 ng/L, respectively). Erythromycin was the most concentrated antibiotic measured in Benson and Oxford WWTPs influent (max=6,870 and 2,930 ng/L, respectively). Napthazoline and oxymetazoline were the most frequently detected and concentrated decongestant in the Benson WWTP influent (1650 and 67 ng/L) and effluent (696 and 307 ng/L), respectively, but were below detection in the Oxford WWTP. OC was found in 73% of November 2009's weekly river samples (max=193 ng/L), but only in 5% and 0% of the late- and inter-pandemic river samples, respectively. The mean river concentration of each antibiotic during the pandemic largely fell between 17-74 ng/L, with clarithromycin (max=292 ng/L) and erythromycin (max=448 ng/L) yielding the highest single measure. In general, the concentration and frequency of detecting antibiotics in the river increased during the pandemic. OC was uniquely well-suited for the wastewater epidemiology approach owing to its nature as a prodrug, recalcitrance and temporally- and spatially-resolved prescription statistics.

摘要

2009年11月,甲型H1N1流感大流行秋季高峰期间,在英格兰泰晤士河流域的21个地点每周测量11种抗生素(甲氧苄啶、土霉素、环丙沙星、阿奇霉素、头孢噻肟、强力霉素、磺胺甲恶唑、红霉素、克拉霉素、氧氟沙星、诺氟沙星)、3种减充血剂(萘甲唑啉、羟甲唑啉、赛洛唑啉)以及抗病毒药物奥司他韦的活性代谢物奥司他韦羧酸盐(OC)的浓度。目的是量化针对该大流行的药物反应,并将其与大流行后期(2010年3月)和大流行间期(2011年5月)的药物使用情况进行比较。2009年11月对一座大型和一座小型污水处理厂进行了采样,以了解两种污水处理厂中分析物在进入受纳河流之前的不同归宿,并采用污水流行病学方法估算药物使用者数量。小型和大型污水处理厂进水的OC平均每小时浓度分别为208和350纳克/升(最高分别为2070和550纳克/升)。红霉素是在本森和牛津污水处理厂进水处测量到的浓度最高的抗生素(最高分别为6870和2930纳克/升)。萘甲唑啉和羟甲唑啉分别是本森污水处理厂进水(1650和67纳克/升)和出水(696和307纳克/升)中检测到且浓度最高的减充血剂,但在牛津污水处理厂中未检出。在2009年11月的河流样本中,73%检测到OC(最高为193纳克/升),但在大流行后期和大流行间期的河流样本中,检出率分别仅为5%和0%。大流行期间,每种抗生素的河流平均浓度大多在17 - 74纳克/升之间,其中克拉霉素(最高为292纳克/升)和红霉素(最高为448纳克/升)的单次测量值最高。总体而言,大流行期间河流中抗生素的浓度和检出频率有所增加。由于OC作为前体药物的性质、难降解性以及在时间和空间上解析的处方统计数据,它特别适合采用污水流行病学方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a18/4177917/4d72bda2d64f/pone.0108621.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a18/4177917/827da68d7d7f/pone.0108621.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a18/4177917/4d72bda2d64f/pone.0108621.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a18/4177917/827da68d7d7f/pone.0108621.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a18/4177917/4d72bda2d64f/pone.0108621.g003.jpg

相似文献

1
Intra- and inter-pandemic variations of antiviral, antibiotics and decongestants in wastewater treatment plants and receiving rivers.污水处理厂及受纳河流中抗病毒药物、抗生素和解充血药在疫情期间及不同疫情间的变化情况。
PLoS One. 2014 Sep 25;9(9):e108621. doi: 10.1371/journal.pone.0108621. eCollection 2014.
2
Occurrence and fate of most prescribed antibiotics in different water environments of Tehran, Iran.伊朗德黑兰不同水环境中大多数规定抗生素的出现和归宿。
Sci Total Environ. 2018 Apr 1;619-620:446-459. doi: 10.1016/j.scitotenv.2017.07.272. Epub 2017 Nov 29.
3
The development and application of a system for simultaneously determining anti-infectives and nasal decongestants using on-line solid-phase extraction and liquid chromatography-tandem mass spectrometry.采用在线固相萃取和液相色谱-串联质谱法同时测定抗感染药和鼻减充血剂的系统的开发与应用。
J Pharm Biomed Anal. 2012 Jul;66:24-32. doi: 10.1016/j.jpba.2012.02.011. Epub 2012 Mar 8.
4
Occurrence of antibiotics in wastewater from hospital and convectional wastewater treatment plants and their impact on the effluent receiving rivers: current knowledge between 2010 and 2019.抗生素在医院和传统污水处理厂废水中的出现及其对受纳河流的影响:2010 年至 2019 年期间的现有知识。
Environ Monit Assess. 2022 Mar 30;194(4):306. doi: 10.1007/s10661-022-09846-4.
5
Antibiotics in Wastewater: Baseline of the Influent and Effluent Streams in Kuwait.科威特废水中的抗生素:进水和出水的基线情况
Toxics. 2022 Apr 1;10(4):174. doi: 10.3390/toxics10040174.
6
Occurrence, removal, and risk assessment of antibiotics in 12 wastewater treatment plants from Dalian, China.中国大连12家污水处理厂中抗生素的存在、去除及风险评估
Environ Sci Pollut Res Int. 2017 Jul;24(19):16478-16487. doi: 10.1007/s11356-017-9296-7. Epub 2017 May 28.
7
Occurrence and prevalence of antibiotics in wastewater treatment plants and effluent receiving rivers in South Africa using UHPLC-MS determination.采用 UHPLC-MS 法测定南非废水处理厂和受纳河流废水中抗生素的出现和流行情况。
J Environ Manage. 2023 Nov 1;345:118621. doi: 10.1016/j.jenvman.2023.118621. Epub 2023 Jul 20.
8
Antibiotics in urban wastewater and rivers of Tehran, Iran: Consumption, mass load, occurrence, and ecological risk.伊朗德黑兰城市废水中和河流中的抗生素:消费、质量负荷、出现情况和生态风险。
Chemosphere. 2019 Apr;221:55-66. doi: 10.1016/j.chemosphere.2018.12.187. Epub 2018 Dec 27.
9
Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan.在日本的污水排放和河水中检测到奥司他韦羧酸,它是奥司他韦磷酸盐(达菲)的活性代谢物。
Environ Health Perspect. 2010 Jan;118(1):103-7. doi: 10.1289/ehp.0900930.
10
Occurrence of sulfonamide residues along the Ebro River basin: removal in wastewater treatment plants and environmental impact assessment.沿埃布罗河流域磺胺类药物残留的出现:污水处理厂的去除及其环境影响评价。
Environ Int. 2011 Feb;37(2):462-73. doi: 10.1016/j.envint.2010.11.011. Epub 2010 Dec 22.

引用本文的文献

1
Characterization of microbiome, resistome, mobilome, and virulome in anoxic and oxic wastewater treatment processes in Slovakia and Taiwan.斯洛伐克和台湾地区缺氧及好氧废水处理过程中微生物组、抗性组、可移动遗传元件组和病毒组的特征分析
Heliyon. 2024 Sep 30;10(19):e38723. doi: 10.1016/j.heliyon.2024.e38723. eCollection 2024 Oct 15.
2
Host- plasmid network structure in wastewater is linked to antimicrobial resistance genes.废水中的宿主-质粒网络结构与抗微生物药物耐药基因有关。
Nat Commun. 2024 Jan 16;15(1):555. doi: 10.1038/s41467-024-44827-w.
3
Evaluation of low-cost SARS-CoV-2 RNA purification methods for viral quantification by RT-qPCR and next-generation sequencing analysis: Implications for wider wastewater-based epidemiology adoption.

本文引用的文献

1
Occurrence and behaviour of 105 active pharmaceutical ingredients in sewage waters of a municipal sewer collection system.城市污水收集系统污水中 105 种活性药物成分的出现和行为。
Water Res. 2014 Jul 1;58:221-9. doi: 10.1016/j.watres.2014.03.076. Epub 2014 Apr 12.
2
Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults.作为儿童和成人急性肺炎抗生素治疗辅助药物的非处方(OTC)止咳药。
Cochrane Database Syst Rev. 2014 Mar 10;2014(3):CD006088. doi: 10.1002/14651858.CD006088.pub4.
3
A novel influenza virus neuraminidase inhibitor AV5027.
用于通过逆转录定量聚合酶链反应(RT-qPCR)和下一代测序分析进行病毒定量的低成本严重急性呼吸综合征冠状病毒2(SARS-CoV-2)RNA纯化方法的评估:对更广泛采用基于废水的流行病学的意义。
Heliyon. 2023 Jun;9(6):e16130. doi: 10.1016/j.heliyon.2023.e16130. Epub 2023 May 16.
4
Impacts of the COVID-19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania.新冠疫情对经处理后用于有益回用的污水中的药品的影响:宾夕法尼亚州中部的两个案例研究。
J Environ Qual. 2022 Sep;51(5):1066-1082. doi: 10.1002/jeq2.20398. Epub 2022 Sep 5.
5
Membrane bioreactors for hospital wastewater treatment: recent advancements in membranes and processes.用于医院污水处理的膜生物反应器:膜及工艺的最新进展
Front Chem Sci Eng. 2022;16(5):634-660. doi: 10.1007/s11705-021-2107-1. Epub 2021 Nov 26.
6
Changes in Sewage Sludge Chemical Signatures During a COVID-19 Community Lockdown, Part 1: Traffic, Drugs, Mental Health, and Disinfectants.新冠疫情社区封锁期间污水污泥化学特征的变化,第 1 部分:交通、毒品、心理健康和消毒剂。
Environ Toxicol Chem. 2022 May;41(5):1179-1192. doi: 10.1002/etc.5217. Epub 2021 Oct 19.
7
Environmental impact assessment of COVID-19 therapeutic solutions. A prospective analysis.新型冠状病毒肺炎治疗方案的环境影响评估。一项前瞻性分析。
Sci Total Environ. 2021 Jul 15;778:146257. doi: 10.1016/j.scitotenv.2021.146257. Epub 2021 Mar 10.
8
Translating antibiotic prescribing into antibiotic resistance in the environment: A hazard characterisation case study.将抗生素处方转化为环境中的抗生素耐药性:危害特征化案例研究。
PLoS One. 2019 Sep 4;14(9):e0221568. doi: 10.1371/journal.pone.0221568. eCollection 2019.
9
Distribution and Chemical Analysis of Pharmaceuticals and Personal Care Products (PPCPs) in the Environmental Systems: A Review.环境系统中药物和个人护理产品(PPCPs)的分布与化学分析:综述。
Int J Environ Res Public Health. 2019 Aug 21;16(17):3026. doi: 10.3390/ijerph16173026.
10
Environmental resistance development to influenza antivirals: a case exemplifying the need for a multidisciplinary One Health approach including physicians.流感抗病毒药物的环境耐药性发展:一个例证需要包括医生在内的多学科“同一健康”方法的案例。
Acta Vet Scand. 2018 Jan 25;60(1):6. doi: 10.1186/s13028-018-0360-1.
新型流感病毒神经氨酸酶抑制剂 AV5027。
Antiviral Res. 2013 Dec;100(3):698-708. doi: 10.1016/j.antiviral.2013.10.008.
4
A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment.关于水环境中微污染物的发生及其在废水处理过程中的迁移转化和去除的综述。
Sci Total Environ. 2014 Mar 1;473-474:619-41. doi: 10.1016/j.scitotenv.2013.12.065. Epub 2014 Jan 4.
5
Assessing exposure risks for aquatic organisms posed by Tamiflu use under seasonal influenza and pandemic conditions.评估在季节性流感和大流行情况下使用达菲对水生生物造成的暴露风险。
Environ Pollut. 2014 Jan;184:377-84. doi: 10.1016/j.envpol.2013.09.019. Epub 2013 Oct 3.
6
Resistance mutation R292K is induced in influenza A(H6N2) virus by exposure of infected mallards to low levels of oseltamivir.流感 A(H6N2)病毒在感染的绿头鸭中接触低水平奥司他韦会诱导产生耐药突变 R292K。
PLoS One. 2013 Aug 12;8(8):e71230. doi: 10.1371/journal.pone.0071230. eCollection 2013.
7
Mass balance of anti-influenza drugs discharged into the Yodo River system, Japan, under an influenza outbreak.在流感爆发期间,排入日本淀川水系的抗流感药物的质量平衡。
Chemosphere. 2013 Nov;93(9):1672-7. doi: 10.1016/j.chemosphere.2013.05.025. Epub 2013 Jul 18.
8
Influence of humans on evolution and mobilization of environmental antibiotic resistome.人类对环境抗生素抗性基因库的进化和转移的影响。
Emerg Infect Dis. 2013 Jul;19(7). doi: 10.3201/eid1907.120871.
9
Compliance to oseltamivir among two populations in Oxfordshire, United Kingdom affected by influenza A(H1N1)pdm09, November 2009--a waste water epidemiology study.英国牛津郡受甲型 H1N1pdm09 流感影响的两个人群对奥司他韦的依从性——一项基于废水流行病学的研究。
PLoS One. 2013 Apr 15;8(4):e60221. doi: 10.1371/journal.pone.0060221. Print 2013.
10
Effect of oseltamivir carboxylate consumption on emergence of drug-resistant H5N2 avian influenza virus in Mallard ducks.奥司他韦羧酸消费对野鸭中耐药性 H5N2 禽流感病毒出现的影响。
Antimicrob Agents Chemother. 2013 May;57(5):2171-81. doi: 10.1128/AAC.02126-12. Epub 2013 Mar 4.